TY - JOUR
T1 - PRIDE-FTG advances academic careers of underrepresented early-stage investigators performing blood disorders research
AU - Pace, Betty S.
AU - Onwuemene, Oluwatoyosi A.
AU - Starlard-Davenport, Athena
AU - Markowitz, Rhea Beth
AU - Heboyan, Vahé
AU - Datsov, Petar
AU - Rice, Treva
N1 - Publisher Copyright:
© 2025 American Society of Hematology.
PY - 2025/8/12
Y1 - 2025/8/12
N2 - Despite improvements in the diversity of the US biomedical research workforce, individuals from different racial/ethnic groups remain underrepresented. Even though mentoring is critical for career advancement, underrepresented faculty have limited opportunities. Therefore, we evaluated a multipronged mentoring approach for early-stage underrepresented faculty trained in the Programs to Increase Diversity Among Individuals Engaged in Health-Related Research–Functional and Translational Genomics of Blood Disorders (PRIDE-FTG). The selection process involved a rigorous review of applications, considering factors such as academic potential, research interests, and commitment to diversity in biomedical research. This yearlong training experience includes 2 summer institutes consisting of lectures, grant-writing workshops, and laboratory practicums. In addition, a mentoring committee, comprised of research, career development, and peer mentors, was established. The National Coordination Core collected program evaluations, grants, publications, and academic promotion data. Since 2007, PRIDE-FTG has trained 114 investigators, including 94 Black/African American investigators and 87 assistant professors; 65 mentees (57%) conducted research related to sickle cell disease. The primary outcome metric for PRIDE-FTG is the submission of an extramural National Institutes of Health or equivalent grant within 2 years of training completion. Notably, 70% of 90 mentees achieved this metric and 44.4% was funded as principal investigators. Finally, 55 mentees were promoted to higher academic ranks, and 90 mentees published 1465 peer-reviewed manuscripts. Our data demonstrated the long-term impact of PRIDE-FTG training on the career advancement of early-stage underrepresented investigators. The success of this structured, mentored training program instills a sense of optimism about the future of diversity in our nation.
AB - Despite improvements in the diversity of the US biomedical research workforce, individuals from different racial/ethnic groups remain underrepresented. Even though mentoring is critical for career advancement, underrepresented faculty have limited opportunities. Therefore, we evaluated a multipronged mentoring approach for early-stage underrepresented faculty trained in the Programs to Increase Diversity Among Individuals Engaged in Health-Related Research–Functional and Translational Genomics of Blood Disorders (PRIDE-FTG). The selection process involved a rigorous review of applications, considering factors such as academic potential, research interests, and commitment to diversity in biomedical research. This yearlong training experience includes 2 summer institutes consisting of lectures, grant-writing workshops, and laboratory practicums. In addition, a mentoring committee, comprised of research, career development, and peer mentors, was established. The National Coordination Core collected program evaluations, grants, publications, and academic promotion data. Since 2007, PRIDE-FTG has trained 114 investigators, including 94 Black/African American investigators and 87 assistant professors; 65 mentees (57%) conducted research related to sickle cell disease. The primary outcome metric for PRIDE-FTG is the submission of an extramural National Institutes of Health or equivalent grant within 2 years of training completion. Notably, 70% of 90 mentees achieved this metric and 44.4% was funded as principal investigators. Finally, 55 mentees were promoted to higher academic ranks, and 90 mentees published 1465 peer-reviewed manuscripts. Our data demonstrated the long-term impact of PRIDE-FTG training on the career advancement of early-stage underrepresented investigators. The success of this structured, mentored training program instills a sense of optimism about the future of diversity in our nation.
UR - https://www.scopus.com/pages/publications/105012210960
U2 - 10.1182/bloodadvances.2024015727
DO - 10.1182/bloodadvances.2024015727
M3 - Article
C2 - 40402127
AN - SCOPUS:105012210960
SN - 2473-9529
VL - 9
SP - 3919
EP - 3928
JO - Blood Advances
JF - Blood Advances
IS - 15
ER -